We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ashland (ASH) to Raise BDO and Derivatives Prices in EMEA
Read MoreHide Full Article
Ashland Global Holdings Inc. (ASH - Free Report) will increase prices of 1-4 butanediol and derivatives in Europe, the Middle East and Africa (EMEA). The price hike will be effective immediately or as contracts permit.
The company will increase the prices of 1-4 butanediol (BDO) by €100/MT and for derivatives (including THF, NMP, BLO, 2-Pyrol) up to €200/MT.
Ashland noted that the price increase reflects evolving market conditions and will help it to continue to serve its customers with the premium level services. The latest move follows a series of price increases announced by the company in the recent past.
Ashland is also taking appropriate pricing actions in response to raw material cost inflation. The company, earlier this month, announced price increase on epoxy vinyl ester and specialty resins in North America, effective from Apr 1, 2018. The move is driven by sustained rise in the costs of major raw materials.
Shares of Ashland have declined 44.6% over a year, significantly underperforming the industry’s 8.7% gain.
Ashland’s earnings and sales missed estimates in first-quarter fiscal 2018 (ended Dec 31, 2017). In the quarter, the company’s adjusted earnings came in at 46 cents per share, trailing the Zacks Consensus Estimate of 47 cents.
Revenues increased roughly 19.6% year over year to $842 million in the quarter. The figure, however, lagged the Zacks Consensus Estimate of $860 million.
For fiscal 2018, Ashland updated its adjusted earnings outlook to a range of $2.90-$3.10 per share owing to changes in the company’s effective tax rate. Also, the company raised effective tax rate expectation for the fiscal as a result of the recently enacted tax reform. This, in turn, is expected to reduce fiscal 2018 adjusted earnings by roughly 30 cents per share.
For second-quarter fiscal 2018, Ashland projects adjusted earnings in the range of 80-90 cents per share compared with 70 cents in the prior-year period. The company expects the benefit of pricing actions to be partly offset in the quarter by the impact of the planned maintenance shutdown in the Marl, Germany, facility.
Ashland currently carries a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks in the basic materials space are LyondellBasell Industries N.V. (LYB - Free Report) , Kronos Worldwide Inc. (KRO - Free Report) and BASF SE (BASFY - Free Report) .
LyondellBasell has an expected long-term earnings growth rate of 9% and sports a Zacks Rank #1 (Strong Buy). The company’s shares have moved up 18% in a year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Kronos has an expected long-term earnings growth rate of 5% and flaunts a Zacks Rank #1. Its shares have gained 43.5% over a year.
BASF has an expected long-term earnings growth rate of 6.7% and carries a Zacks Rank #2 (Buy). Its shares have moved up 1.3% in a year.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Ashland (ASH) to Raise BDO and Derivatives Prices in EMEA
Ashland Global Holdings Inc. (ASH - Free Report) will increase prices of 1-4 butanediol and derivatives in Europe, the Middle East and Africa (EMEA). The price hike will be effective immediately or as contracts permit.
The company will increase the prices of 1-4 butanediol (BDO) by €100/MT and for derivatives (including THF, NMP, BLO, 2-Pyrol) up to €200/MT.
Ashland noted that the price increase reflects evolving market conditions and will help it to continue to serve its customers with the premium level services. The latest move follows a series of price increases announced by the company in the recent past.
Ashland is also taking appropriate pricing actions in response to raw material cost inflation. The company, earlier this month, announced price increase on epoxy vinyl ester and specialty resins in North America, effective from Apr 1, 2018. The move is driven by sustained rise in the costs of major raw materials.
Shares of Ashland have declined 44.6% over a year, significantly underperforming the industry’s 8.7% gain.
Ashland’s earnings and sales missed estimates in first-quarter fiscal 2018 (ended Dec 31, 2017). In the quarter, the company’s adjusted earnings came in at 46 cents per share, trailing the Zacks Consensus Estimate of 47 cents.
Revenues increased roughly 19.6% year over year to $842 million in the quarter. The figure, however, lagged the Zacks Consensus Estimate of $860 million.
For fiscal 2018, Ashland updated its adjusted earnings outlook to a range of $2.90-$3.10 per share owing to changes in the company’s effective tax rate. Also, the company raised effective tax rate expectation for the fiscal as a result of the recently enacted tax reform. This, in turn, is expected to reduce fiscal 2018 adjusted earnings by roughly 30 cents per share.
For second-quarter fiscal 2018, Ashland projects adjusted earnings in the range of 80-90 cents per share compared with 70 cents in the prior-year period. The company expects the benefit of pricing actions to be partly offset in the quarter by the impact of the planned maintenance shutdown in the Marl, Germany, facility.
Ashland Global Holdings Inc. Price and Consensus
Ashland Global Holdings Inc. Price and Consensus | Ashland Global Holdings Inc. Quote
Zacks Rank & Stocks to Consider
Ashland currently carries a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks in the basic materials space are LyondellBasell Industries N.V. (LYB - Free Report) , Kronos Worldwide Inc. (KRO - Free Report) and BASF SE (BASFY - Free Report) .
LyondellBasell has an expected long-term earnings growth rate of 9% and sports a Zacks Rank #1 (Strong Buy). The company’s shares have moved up 18% in a year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Kronos has an expected long-term earnings growth rate of 5% and flaunts a Zacks Rank #1. Its shares have gained 43.5% over a year.
BASF has an expected long-term earnings growth rate of 6.7% and carries a Zacks Rank #2 (Buy). Its shares have moved up 1.3% in a year.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>